Dr. Xingchen Bian (Shanghai, China)
Dr. Xingchen Bian specializes in antimicrobial pharmacology, clinical pharmacology, and pharmacometrics. Her research focuses on using in vitro pharmacokinetic/pharmacodynamic and omics technologies to explore the effects of polymyxin combination therapy, with particular emphasis on the synergistic mechanisms related to cell membranes. Utilizing her experience in early-phase clinical trials for innovative antimicrobials, Dr. Bian actively employs model-informed drug development strategies to support the research and development of new pharmaceuticals.
Dr. Xingchen Bian specializes in antimicrobial pharmacology, clinical pharmacology, and pharmacometrics. Her research focuses on using in vitro pharmacokinetic/pharmacodynamic and omics technologies to explore the effects of polymyxin combination therapy, with particular emphasis on the synergistic mechanisms related to cell membranes. Utilizing her experience in early-phase clinical trials for innovative antimicrobials, Dr. Bian actively employs model-informed drug development strategies to support the research and development of new pharmaceuticals.